Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cohbar, Inc. | 200,000 | reported | 26 Apr 2021 | tx 2+400,000 |
| MIMEDX GROUP, INC. | 117,024 | reported | 13 Jun 2023 | tx 5+117,024 |
| AEROGEN INC | 20,000 | reported | 27 Jul 2004 | tx 1+20,000 |
| Revance Therapeutics, Inc. | 12,000 | reported | 14 May 2020 | tx 25+541,251−462,418 |
| Corium International, Inc. | 0 | reported | 27 Nov 2018 | tx 14+89,342−129,187 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2023 | GRANT_AWARD | MIMEDX GROUP, INC. | 35,354 | 4.95 USD | |
| 07 Jun 2022 | GRANT_AWARD | MIMEDX GROUP, INC. | 44,191 | 3.96 USD | |
| 27 May 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 17,056 | 10.26 USD | |
| 28 Apr 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 16,339 | 10.71 USD | |
| 28 Apr 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 4,084 | 10.71 USD | |
| 26 Apr 2021 | GRANT_AWARD | Cohbar, Inc. | 200,000 | 0.00 USD | deriv |
| 14 May 2020 | GRANT_AWARD | Revance Therapeutics, Inc. | 6,000 | 0.00 USD | |
| 14 May 2020 | GRANT_AWARD | Revance Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 09 May 2019 | GRANT_AWARD | Revance Therapeutics, Inc. | 4,500 | 0.00 USD | |
| 09 May 2019 | GRANT_AWARD | Revance Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 08 Feb 2019 | GRANT_AWARD | Cohbar, Inc. | 200,000 | 0.00 USD | deriv |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 34,203 | 12.50 USD | |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 7,920 | 12.50 USD | deriv |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 12,000 | 12.50 USD | deriv |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 15,000 | 12.50 USD | deriv |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 15,000 | 12.50 USD | deriv |
| 27 Nov 2018 | OTHER | Corium International, Inc. | 12,000 | 12.50 USD | deriv |
| 10 May 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 3,000 | 0.00 USD | |
| 10 May 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 16 Mar 2018 | EXERCISE | Revance Therapeutics, Inc. | 1,333 | 2.55 USD | |
| 16 Mar 2018 | EXERCISE | Revance Therapeutics, Inc. | 4,000 | 2.55 USD | |
| 16 Mar 2018 | SALE | Revance Therapeutics, Inc. | 5,333 | 31.51 USD | |
| 16 Mar 2018 | EXERCISE | Revance Therapeutics, Inc. | 1,333 | 0.00 USD | deriv |
| 16 Mar 2018 | EXERCISE | Revance Therapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 01 Dec 2017 | GRANT_AWARD | Corium International, Inc. | 15,000 | 0.00 USD | deriv |